{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:56:13Z","timestamp":1783468573197,"version":"3.55.0"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T00:00:00Z","timestamp":1594080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["18-74-00125"],"award-info":[{"award-number":["18-74-00125"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.01010","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T06:27:43Z","timestamp":1594103263000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Tuning Scorpion Toxin Selectivity: Switching From KV1.1 to KV1.3"],"prefix":"10.3389","volume":"11","author":[{"given":"Andrei M.","family":"Gigolaev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey I.","family":"Kuzmenkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Peigneur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin M.","family":"Tabakmakher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto L.","family":"Pinheiro-Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton O.","family":"Chugunov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman G.","family":"Efremov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Tytgat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A.","family":"Vassilevski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/0896-6273(95)90104-3","article-title":"Topology of the pore-region of a K+ channel revealed by the NMR-derived structures of scorpion toxins","volume":"15","author":"Aiyar","year":"1995","journal-title":"Neuron"},{"key":"B3","doi-asserted-by":"publisher","first-page":"S142","DOI":"10.1111\/bph.14749","article-title":"THE CONCISE GUIDE TO PHARMACOLOGY 2019\/20: Ion channels","volume":"176","author":"Alexander","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"B4","doi-asserted-by":"crossref","unstructured":"Voltage-gated potassium channels (version 2019.4) in the IUPHAR\/BPS Guide to Pharmacology Database\n            AttaliB.\n            ChandyK. G.\n            GieseM. H.\n            GrissmerS.\n            GutmanG. A.\n            JanL. Y.\n          10.2218\/gtopdb\/F81\/2019.42019","DOI":"10.2218\/gtopdb\/F41\/2019.4"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.00594","article-title":"Structure of a pore-blocking toxin in complex with a eukaryotic voltage-dependent K(+) channel","volume":"2","author":"Banerjee","year":"2013","journal-title":"Elife"},{"key":"B6","doi-asserted-by":"publisher","first-page":"17414","DOI":"10.1073\/pnas.0605136103","article-title":"Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases","volume":"103","author":"Beeton","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J. Chem. Phys."},{"key":"B8","doi-asserted-by":"publisher","first-page":"18349","DOI":"10.1074\/jbc.RA119.010494","article-title":"Protein surface topography as a tool to enhance the selective activity of a potassium channel blocker","volume":"294","author":"Berkut","year":"2019","journal-title":"J. Biol. Chem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"014101","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J. Chem. Phys."},{"key":"B10","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nature19467","article-title":"Channelling potassium to fight cancer","volume":"537","author":"Chandy","year":"2016","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cbpa.2017.02.015","article-title":"Peptide blockers of Kv1.3 channels in T cells as therapeutics for autoimmune disease","volume":"38","author":"Chandy","year":"2017","journal-title":"Curr. Opin. Chem. Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.tips.2004.03.010","article-title":"K+ channels as targets for specific immunomodulation","volume":"25","author":"Chandy","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"11352","DOI":"10.1073\/pnas.1000142107","article-title":"Structure of the full-length Shaker potassium channel Kv1.2 by normal-mode-based X-ray crystallographic refinement","volume":"107","author":"Chen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.toxicon.2014.02.010","article-title":"Functional and structural study comparing the C-terminal amidated \u03b2-neurotoxin Ts1 with its isoform Ts1-G isolated from Tityus serrulatus venom","volume":"83","author":"Coelho","year":"2014","journal-title":"Toxicon"},{"key":"B15","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nri3233","article-title":"Ion channels and transporters in lymphocyte function and immunity","volume":"12","author":"Feske","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.biochi.2010.08.003","article-title":"A potent potassium channel blocker from Mesobuthus eupeus scorpion venom","volume":"92","author":"Gao","year":"2010","journal-title":"Biochimie"},{"key":"B17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.pep.2011.04.005","article-title":"Strategy for improvement of enteropeptidase efficiency in tag removal processes","volume":"79","author":"Gasparian","year":"2011","journal-title":"Protein Expr. Purif."},{"key":"B18","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.toxicon.2003.11.029","article-title":"Molecular basis of \u03b1-KTx specificity","volume":"43","author":"Giangiacomo","year":"2004","journal-title":"Toxicon"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/0896-6273(94)90452-9","article-title":"The charybdotoxin receptor of a Shaker K+ channel: peptide and channel residues mediating molecular recognition","volume":"12","author":"Goldstein","year":"1994","journal-title":"Neuron"},{"key":"B20","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0896-6273(00)80057-4","article-title":"Agitoxin Footprinting the Shaker Potassium Channel Pore","volume":"16","author":"Gross","year":"1996","journal-title":"Neuron"},{"key":"B21","doi-asserted-by":"publisher","first-page":"19058","DOI":"10.1074\/jbc.M802054200","article-title":"Structural basis of a potent peptide inhibitor designed for Kv1.3 channel, a therapeutic target of autoimmune disease","volume":"283","author":"Han","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.103746","article-title":"Design and characterization of a novel structural class of Kv1.3 inhibitors","volume":"98","author":"Hendrickx","year":"2020","journal-title":"Bioorg. Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1126\/science.7716527","article-title":"Revealing the architecture of a K+ channel pore through mutant cycles with a peptide inhibitor","volume":"268","author":"Hidalgo","year":"1995","journal-title":"Science"},{"key":"B24","volume-title":"Ion Channels of Excitable Membranes.","author":"Hille","year":"2001"},{"key":"B25","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J.\u00a0Chem. Phys."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1517\/14712598.2011.621940","article-title":"Venoms as a platform for human drugs: translating toxins into therapeutics","volume":"11","author":"King","year":"2011","journal-title":"Expert Opin. Biol. Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1002\/prot.22711","article-title":"Improved side-chain torsion potentials for the Amber ff99SB protein force field","volume":"78","author":"Klepeis","year":"2010","journal-title":"Proteins Struct. Funct. Bioinforma."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.4155\/FMC.14.98","article-title":"Computational approaches for designing potent and selective analogs of peptide toxins as novel therapeutics","volume":"6","author":"Kuyucak","year":"2014","journal-title":"Future Med. Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1134\/S0006297915130118","article-title":"Diversity of Potassium Channel Ligands: Focus on Scorpion Toxins","volume":"80","author":"Kuzmenkov","year":"2015","journal-title":"Biochem (Mosc.)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"12195","DOI":"10.1074\/jbc.M115.637611","article-title":"Variability of potassium channel blockers in Mesobuthus eupeus scorpion venom with focus on Kv1.1: An integrated transcriptomic and proteomic study","volume":"290","author":"Kuzmenkov","year":"2015","journal-title":"J. Biol. Chem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"pii: baw056","DOI":"10.1093\/database\/baw056","article-title":"Kalium: a database of potassium channel toxins from scorpion venom","volume":"2016","author":"Kuzmenkov","year":"2016","journal-title":"Database (Oxford)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1042\/BCJ20160436","article-title":"Lachesana tarabaevi, an expert in membrane-active toxins","volume":"473","author":"Kuzmenkov","year":"2016","journal-title":"Biochem. J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.bbapap.2017.02.001","article-title":"C-Terminal residues in small potassium channel blockers OdK1 and OSK3 from scorpion venom fine-tune the selectivity","volume":"1865","author":"Kuzmenkov","year":"2017","journal-title":"Biochim. Biophys. Acta Proteins Proteomics"},{"key":"B34","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.neuropharm.2018.09.030","article-title":"KV1.2 channel-specific blocker from Mesobuthus eupeus scorpion venom: Structural basis of selectivity","volume":"143","author":"Kuzmenkov","year":"2018","journal-title":"Neuropharmacology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1134\/S0869813919110074","article-title":"Pharmacological Characterisation of MeKTx13-2 and MeKTx13-3, Peptide Ligands of Potassium Channels From the Scorpion Mesobuthus eupeus Venom","volume":"105","author":"Kuzmenkov","year":"2019","journal-title":"Russ. J. Physiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1042\/bj3280321","article-title":"A four-disulphide-bridged toxin, with high affinity towards voltage-gated K+ channels, isolated from Heterometrus spinnifer (Scorpionidae) venom","volume":"328","author":"Lebrun","year":"1997","journal-title":"Biochem. J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"Unit16.8","DOI":"10.1002\/0471142727.mb1608s28","article-title":"Expression and Purification of Thioredoxin Fusion Proteins","volume":"28","author":"McCoy","year":"1994","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/0141-0229(94)90014-0","article-title":"C-terminal Amidated Peptides: Production by the in Vitro Enzymatic Amidation of Glycine-Extended Peptides and the Importance of the Amide to Bioactivity","volume":"16","author":"Merkler","year":"1994","journal-title":"Enzyme Microb. Technol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1042\/bj20031860","article-title":"Diversity of folds in animal toxins acting on ion channels","volume":"378","author":"Mouhat","year":"2004","journal-title":"Biochem. J."},{"key":"B40","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1042\/BJ20041379","article-title":"K+ channel types targeted by synthetic OSK1, a toxin from Orthochirus scrobiculosus scorpion venom","volume":"385","author":"Mouhat","year":"2005","journal-title":"Biochem. J."},{"key":"B41","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.neuropharm.2017.07.002","article-title":"Venom-derived peptide inhibitors of voltage-gated potassium channels","volume":"127","author":"Norton","year":"2017","journal-title":"Neuropharmacology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrc3635","article-title":"The roles of K(+) channels in cancer","volume":"14","author":"Pardo","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"B43","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.bcp.2011.03.023","article-title":"A bifunctional sea anemone peptide with Kunitz type protease and potassium channel inhibiting properties","volume":"82","author":"Peigneur","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1124\/mol.108.052704","article-title":"Engineering a stable and selective peptide blocker of the Kv1.3 channel in T lymphocytes","volume":"75","author":"Pennington","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.1016\/J.FEBSLET.2012.09.038","article-title":"A C-terminally Amidated Analogue of ShK Is a Potent and Selective Blocker of the Voltage-Gated Potassium Channel Kv1.3","volume":"586","author":"Pennington","year":"2012","journal-title":"FEBS Lett."},{"key":"B46","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.toxicon.2007.07.004","article-title":"\u03c9-Lsp-IA, a novel modulator of P-type Ca2+ channels","volume":"50","author":"Pluzhnikov","year":"2007","journal-title":"Toxicon"},{"key":"B47","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1177\/2472555219864894","article-title":"Targeting the Mitochondrial Potassium Channel Kv1.3 to Kill Cancer Cells: Drugs, Strategies, and New Perspectives","volume":"24","author":"Prosdocimi","year":"2019","journal-title":"SLAS Discovery Adv. Life Sci. R D"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3390\/i8111083","article-title":"A Fragment-Based Scoring Function to Re-rank ATP Docking Results","volume":"8","author":"Pyrkov","year":"2007","journal-title":"Int. J. Mol. Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1093\/bioinformatics\/btp111","article-title":"PLATINUM: a web tool for analysis of hydrophobic\/hydrophilic organization of biomolecular complexes","volume":"25","author":"Pyrkov","year":"2009","journal-title":"Bioinformatics"},{"key":"B50","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.1038\/srep04509","article-title":"A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseases","volume":"4","author":"Rashid","year":"2015","journal-title":"Sci. Rep."},{"key":"B51","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/(SICI)1097-0134(20000101)38:1<70::AID-PROT8>3.0.CO;2-5","article-title":"Solution structure of BmKTX, a K+ blocker toxin from the Chinese scorpion Buthus Martensi","volume":"38","author":"Renisio","year":"2000","journal-title":"Proteins"},{"key":"B52","doi-asserted-by":"publisher","first-page":"13473","DOI":"10.1021\/bi971044w","article-title":"Purification, characterization, and synthesis of three novel toxins from the Chinese scorpion Buthus martensi, which act on K+ channels","volume":"36","author":"Romi-Lebrun","year":"1997","journal-title":"Biochemistry"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1124\/mol.105.015669","article-title":"Design of PAP-1, a Selective Small Molecule Kv1.3 Blocker, for the Suppression of Effector Memory T Cells in Autoimmune Diseases","volume":"68","author":"Schmitz","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41597-019-0074-x","article-title":"Kalium 2.0, a comprehensive database of polypeptide ligands of potassium channels","volume":"6","author":"Tabakmakher","year":"2019","journal-title":"Sci. Data"},{"key":"B55","doi-asserted-by":"publisher","first-page":"22211","DOI":"10.1073\/pnas.0910123106","article-title":"A designer ligand specific for Kv1.3 channels from a scorpion neurotoxin-based library","volume":"106","author":"Takacs","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00933","article-title":"Voltage-Gated Potassium Channel Kv1.3 as a Target in Therapy of Cancer","volume":"9","author":"Teisseyre","year":"2019","journal-title":"Front. Oncol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1124\/mol.112.078006","article-title":"Vm24, a natural immunosuppressive peptide, potently and selectively blocks Kv1.3 potassium channels of human T cells","volume":"82","author":"Varga","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"5.6.1","DOI":"10.1002\/cpbi.3","article-title":"Comparative Protein Structure Modeling Using MODELLER","volume":"54","author":"Webb","year":"2016","journal-title":"Curr. Protoc. Bioinf."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1021\/cr078234p","article-title":"K+ channel modulators for the treatment of neurological disorders and autoimmune diseases","volume":"108","author":"Wulff","year":"2008","journal-title":"Chem. Rev."},{"key":"B60","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41573-019-0013-8","article-title":"Antibodies and venom peptides: new modalities for ion channels","volume":"18","author":"Wulff","year":"2019","journal-title":"Nat. Rev. Drug Discovery"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.01010\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T06:27:48Z","timestamp":1594103268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.01010\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,7]]},"references-count":60,"alternative-id":["10.3389\/fphar.2020.01010"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.01010","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,7]]},"article-number":"1010"}}